Ecallantide for the treatment of acute attacks in hereditary angioedema.
Cicardi, Marco
Ecallantide for the treatment of acute attacks in hereditary angioedema. [electronic resource] - The New England journal of medicine Aug 2010 - 523-31 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa0905079 doi
Acute Disease
Adolescent
Adult
Aged
Angioedemas, Hereditary--drug therapy
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Intention to Treat Analysis
Kallikreins--antagonists & inhibitors
Kaplan-Meier Estimate
Logistic Models
Male
Middle Aged
Peptides--adverse effects
Statistics, Nonparametric
Young Adult
Ecallantide for the treatment of acute attacks in hereditary angioedema. [electronic resource] - The New England journal of medicine Aug 2010 - 523-31 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1533-4406
10.1056/NEJMoa0905079 doi
Acute Disease
Adolescent
Adult
Aged
Angioedemas, Hereditary--drug therapy
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Intention to Treat Analysis
Kallikreins--antagonists & inhibitors
Kaplan-Meier Estimate
Logistic Models
Male
Middle Aged
Peptides--adverse effects
Statistics, Nonparametric
Young Adult